Article
Successful rhIGF1 treatment for over 5 years in a patient with severe insulin resistance due to homozygous insulin receptor mutation.
Diabetic medicine : a journal of the British Diabetic Association - 1 Mar 2016
Carmody D, Ladsaria S S, Buikema R K, Semple R K, Greeley S A W
Abstract excerpt
BACKGROUND: Congenital insulin resistance syndromes are caused by biallelic mutations within the insulin receptor gene (INSR). Recombinant human insulin-like growth factor (rhIGF1) has been used with mixed success; however, rigorous assessment of its efficacy is lacking. Here, we describe a child with a homozygous mutation in INSR successfully treated with rhIGF1 for more than 5 years. CASE REPORT: The patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
